RWP
GILD icon

RWA Wealth Partners’s Gilead Sciences GILD Stock Holding History

RWA Wealth Partners’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.34M Buy
34,341
+551
+2% +$72.6K 0.04% 186
2026
Q1 		$4.71M Buy
33,790
+1,643
+5% +$230K 0.05% 167
2025
Q4 		$3.95M Buy
32,147
+2,433
+8% +$296K 0.04% 191
2025
Q3 		$3.3M Buy
29,714
+556
+2% +$63.2K 0.04% 213
2025
Q2 		$3.23M Buy
29,158
+254
+0.9% +$27K 0.04% 198
2025
Q1 		$3.24M Sell
28,904
-3,533
-11% -$365K 0.04% 192
2024
Q4 		$3M Sell
32,437
-173
-0.5% -$15.6K 0.04% 204
2024
Q3 		$2.73M Buy
32,610
+1,290
+4% +$98.4K 0.03% 214
2024
Q2 		$2.15M Sell
31,320
-2,175
-6% -$145K 0.03% 228
2024
Q1 		$2.45M Buy
33,495
+291
+0.9% +$22.4K 0.03% 212
2023
Q4 		$2.69M Buy
33,204
+250
+0.8% +$19.5K 0.04% 197
2023
Q3 		$2.47M Sell
32,954
-321
-1% -$24.7K 0.05% 121
2023
Q2 		$2.56M Buy
+33,275
New +$2.65M 0.06% 113
2021
Q4 		– Sell
-3,323
Closed -$232K – 256
2021
Q3 		$232K Hold
3,323
– – 0.02% 228
2021
Q2 		$229K Buy
3,323
+42
+1% +$2.8K 0.02% 228
2021
Q1 		$212K Buy
+3,281
New +$212K 0.02% 232
2020
Q4 		– Sell
-3,352
Closed -$212K – 236
2020
Q3 		$212K Sell
3,352
-273
-8% -$18.9K 0.02% 202
2020
Q2 		$279K Buy
+3,625
New +$278K 0.03% 180
2018
Q3 		– Sell
-1,214
Closed -$86K – 426
2018
Q2 		$86K Sell
1,214
-45,813
-97% -$3.24M 0.01% 340
2018
Q1 		$3.54M Sell
47,027
-9,252
-16% -$735K 0.46% 54
2017
Q4 		$4.03M Sell
56,279
-10,513
-16% -$798K 0.45% 56
2017
Q3 		$5.41M Buy
66,792
+1,571
+2% +$120K 0.61% 41
2017
Q2 		$4.62M Buy
65,221
+3,114
+5% +$207K 0.57% 47
2017
Q1 		$4.22M Buy
+62,107
New +$4.37M 0.55% 49

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

RWA Wealth Partners's GILD Position: Q2 2026 in Review

RWA Wealth Partners increased its Gilead Sciences (GILD) stake by 1.6% in Q2 2026, buying an estimated $72.6K and bringing the position to 34,341 shares worth $4.34M. The position accounts for 0.04% of the portfolio, ranked #186.

RWA Wealth Partners first reported a position in GILD in Q1 2017 and has held it in 24 quarters since. The position peaked at $5.41M in Q3 2017. 2,278 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • RWA Wealth Partners held 34,341 shares of Gilead Sciences worth $4.34M as of Q2 2026.
  • RWA Wealth Partners bought 551 Gilead Sciences shares in Q2 2026, an estimated $72.6K.
  • Gilead Sciences made up 0.04% of RWA Wealth Partners's portfolio in Q2 2026, its #186 holding.
  • RWA Wealth Partners first reported a position in Gilead Sciences in Q1 2017 and has held it in 24 quarters since.
  • RWA Wealth Partners's Gilead Sciences position peaked at $5.41M in Q3 2017.
  • 2,278 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on RWA Wealth Partners's 13F filing for Q2 2026, filed 7 Aug 2026.